Silencing of lncRNA HOTAIR Using Eyedrops as a Potential Treatment for Diabetes-Associated Retinal Dysregulation and Dysfunction
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.1.24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Eric Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada. Hauptthemen laut MEDLINE: Diabetic Retinopathy, RNA, Long Noncoding, RNA, Small Interfering, Gene Silencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
- i-RNA Corporation, London, Ontario, Canada.
Zitieren
APA
Wang, E., Feng, B., Chen, S., Wang, H., Ling, T., & Chakrabarti, S. (2026). Silencing of lncRNA HOTAIR Using Eyedrops as a Potential Treatment for Diabetes-Associated Retinal Dysregulation and Dysfunction. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.1.24
Vancouver
Wang E, Feng B, Chen S, Wang H, Ling T, Chakrabarti S. Silencing of lncRNA HOTAIR Using Eyedrops as a Potential Treatment for Diabetes-Associated Retinal Dysregulation and Dysfunction. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.1.24
BibTeX
@article{Wang2026,
author = {Wang, Eric and Feng, Biao and Chen, Shali and Wang, Honglin and Ling, Ting and Chakrabarti, Subrata},
title = {Silencing of lncRNA HOTAIR Using Eyedrops as a Potential Treatment for Diabetes-Associated Retinal Dysregulation and Dysfunction},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.1.24}
}
EUVIMED